You are here

US trial of AstraZeneca Covid-19 vaccine may resume this week: sources

rk_astrazeneca_211020.jpg
AstraZeneca Plc's Covid-19 vaccine trial in the United States is expected to resume as early as this week after the US Food and Drug Administration completed its review of a serious illness in a study participant, four sources told Reuters.

[CHICAGO] AstraZeneca Plc's Covid-19 vaccine trial in the United States is expected to resume as early as this week after the US Food and Drug Administration completed its review of a serious illness in a study participant, four sources told Reuters.

AstraZeneca's large, late-stage US...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes